Accessible Requires Authentication Published by De Gruyter May 1, 2018

Manfred Schmitt (1947–2018)

Ute Reuning, Viktor Magdolen, Yves Courty, Judith A. Clements, George M. Yousef, Andreas Scorilas ORCID logo, Maroulio Talieri and Eleftherios P. Diamandis
From the journal Biological Chemistry


Aubele, M., Schmitt, M., Napieralski, R., Paepke, S., Ettl, J., Absmaier, M., Magdolen, V., Martens, J., Foekens, J.A., Wilhelm, O.G., et al. (2017). The predictive value of PITX2 DNA methylation for high-risk breast cancer therapy: current guidelines, medical needs, and challenges. Dis. Markers 2017, 4934608. Search in Google Scholar

Dorn, J., Bayani, J., Yousef, G.M., Yang, F., Magdolen, V., Kiechle, M., Diamandis, E.P., and Schmitt, M. (2013). Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thromb. Haemost. 110, 408–422. Search in Google Scholar

Duffy, M.J., McGowan, P.M., Harbeck, N., Thomssen, C., and Schmitt, M. (2014). uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Res. 16, 428. Search in Google Scholar

Published Online: 2018-05-01
Published in Print: 2018-09-25

©2018 Walter de Gruyter GmbH, Berlin/Boston